These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12690168)

  • 21. Simultaneous detection of free and total prostate specific antigen on a screen-printed electrochemical dual sensor.
    Escamilla-Gómez V; Hernández-Santos D; González-García MB; Pingarrón-Carrazón JM; Costa-García A
    Biosens Bioelectron; 2009 Apr; 24(8):2678-83. PubMed ID: 19261459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of free prostate-specific antigen measurement in prostate-specific antigen screening for prostate cancer.
    Johnson L
    Clin Prostate Cancer; 2002 Dec; 1(3):142-4. PubMed ID: 15046688
    [No Abstract]   [Full Text] [Related]  

  • 23. MOSFET-Embedded microcantilevers for measuring deflection in biomolecular sensors.
    Shekhawat G; Tark SH; Dravid VP
    Science; 2006 Mar; 311(5767):1592-5. PubMed ID: 16456038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific antigen and screening for prostate cancer.
    Han M; Gann PH; Catalona WJ
    Med Clin North Am; 2004 Mar; 88(2):245-65, ix. PubMed ID: 15049577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Techniques and predictive models to improve prostate cancer detection.
    Herman MP; Dorsey P; John M; Patel N; Leung R; Tewari A
    Cancer; 2009 Jul; 115(13 Suppl):3085-99. PubMed ID: 19544550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pox viral vaccine approaches.
    Arlen PM; Kaufman HL; DiPaola RS
    Semin Oncol; 2005 Dec; 32(6):549-55. PubMed ID: 16338420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
    Hayes JH; Barry MJ; Kantoff PW; Stahl JE
    BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
    [No Abstract]   [Full Text] [Related]  

  • 28. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.
    Lin DW
    Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PSA testing.
    Frydenberg M
    Aust Fam Physician; 2003 Jun; 32(6):396. PubMed ID: 12833760
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostate-specific antigen kinetics and the diagnosis and management of prostate cancer.
    Goldstraw MA; Fitzpatrick JM; Kirby RS
    BJU Int; 2006 Dec; 98(6):1141-2. PubMed ID: 17125469
    [No Abstract]   [Full Text] [Related]  

  • 31. [The prostate specific antigen: what can we learn from the American experience?].
    Zhao XJ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
    [No Abstract]   [Full Text] [Related]  

  • 32. A dielectric-modulated field-effect transistor for biosensing.
    Im H; Huang XJ; Gu B; Choi YK
    Nat Nanotechnol; 2007 Jul; 2(7):430-4. PubMed ID: 18654328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of prostate-specific antigen in prostate cancer.
    Liang SL
    MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
    [No Abstract]   [Full Text] [Related]  

  • 34. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
    Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F
    BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient education. PSA: pros and cons.
    Gattellari M; Ward JE
    Aust Fam Physician; 2003 Jun; 32(6):429-30. PubMed ID: 12833769
    [No Abstract]   [Full Text] [Related]  

  • 36. Excellent policy forum series on prostate cancer.
    Dickey RA
    N C Med J; 2006; 67(4):333; author reply 333. PubMed ID: 17066673
    [No Abstract]   [Full Text] [Related]  

  • 37. Direct electronic detection of prostate-specific antigen in serum.
    Briman M; Artukovic E; Zhang L; Chia D; Goodglick L; Gruner G
    Small; 2007 May; 3(5):758-62. PubMed ID: 17352433
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
    Etzioni RD; Ankerst DP; Thompson IM
    J Natl Cancer Inst; 2007 Mar; 99(6):489-90; author reply 490. PubMed ID: 17374841
    [No Abstract]   [Full Text] [Related]  

  • 39. [The search for better markers for prostate cancer than prostate-specific antigen].
    Schenk-Braat EA; Bangma CH
    Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1286-90. PubMed ID: 16821452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.